STING1 and metabolic dysfunction-associated steatotic liver disease: STING activation may yet be associated with exacerbated pro-inflammatory responses of Mφ in chronic inflammatory diseases, such as non-alcoholic fatty liver disease (NAFLD) and hepatic fibrosis (66, 75).